As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/16/24  Axim Biotechnologies, Inc.        10-K       12/31/23   84:7.2M                                   Southridge Svcs Inc./FA  
  4/1/24  Axim Biotechnologies, Inc.        NT 10-K    12/31/23    1:17K                                    Southridge Svcs Inc./FA  
 3/21/24  Axim Biotechnologies, Inc.        8-K:1,2,9   3/15/24   16:302K                                   Southridge Svcs Inc./FA  
 3/19/24  Huemoeller John Walter II         4/A        Dir.,Off.²  1:7K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 3/19/24  Valencia Catalina                 4          10% Owner²  1:5K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 3/19/24  Schroeder Blake                   4          Director²   1:5K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 3/19/24  Cunningham Robert L               4          Director²   1:5K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 3/19/24  Scott Timothy Richard             4          Director²   1:5K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 3/19/24  O’Rourke Peter                    4          Director²   1:5K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 3/19/24  Malasek Robert                    4          Officer²    1:5K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 3/19/24  Huemoeller John Walter II         4          Dir.,Off.²  1:5K   Axim Biotechnologies, Inc.        Southridge Svcs Inc./FA  
 2/13/24  Axim Biotechnologies, Inc.        8-K:1,3      2/7/24   11:143K                                   Southridge Svcs Inc./FA  
12/28/23  Axim Biotechnologies, Inc.        8-K:1,3,9  12/26/23   13:259K                                   Southridge Svcs Inc./FA  
11/20/23  Axim Biotechnologies, Inc.        10-Q        9/30/23   73:6.4M                                   Southridge Svcs Inc./FA  
11/14/23  Axim Biotechnologies, Inc.        NT 10-Q     9/30/23    1:19K                                    Southridge Svcs Inc./FA  
 9/21/23  Axim Biotechnologies, Inc.        DEF 14C     9/21/23    1:89K                                    Southridge Svcs Inc./FA  
 8/31/23  Axim Biotechnologies, Inc.        PRE 14C     8/30/23    1:88K                                    Southridge Svcs Inc./FA  
 8/21/23  Axim Biotechnologies, Inc.        10-Q        6/30/23   73:6.9M                                   Southridge Svcs Inc./FA  
 8/14/23  Axim Biotechnologies, Inc.        NT 10-Q     6/30/23    1:17K                                    Southridge Svcs Inc./FA  
  6/9/23‡ Axim Biotechnologies, Inc.        EFFECT       6/9/23    1:2K                                     SEC #5                   

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	DEF 14C	Definitive Proxy Info Statement — Schedule 14C.
	EFFECT	SEC Notice of Effectiveness.
	NT 10-K	Notice of a Late Filing of a Form 10-K Annual Report — Form 12b-25.
	NT 10-Q	Notice of a Late Filing of a Form 10-Q Quarterly Report — Form 12b-25.
	PRE 14C	Preliminary Proxy Info Statement — Schedule 14C.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.